• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由非典型神经阻滞剂引起的神经阻滞剂恶性综合征,并对劳拉西泮有反应。

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam.

机构信息

Department of Psychiatry and Behavioral Science, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA.

出版信息

Neuropsychiatr Dis Treat. 2006 Jun;2(2):235-40. doi: 10.2147/nedt.2006.2.2.235.

DOI:10.2147/nedt.2006.2.2.235
PMID:19412469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2671780/
Abstract

OBJECTIVE

The authors report three cases of neuroleptic malignant syndrome (NMS) induced by atypical antipsychotics (olanzapine and clozapine) which showed classic features of NMS including muscular rigidity and prominent fever.

METHOD

Case reports.

RESULTS

A 66-year-old man with dementia and alcohol abuse developed NMS while on olanzapine for agitation and combativeness. A 62-year-old man with schizophrenia developed NMS 6 days after starting clozapine. A 43-year-old man with bipolar disorder developed NMS 14 days after starting clozapine. All three cases showed classic features of NMS including muscular rigidity and fever. Resolution of fever and muscular rigidity occurred within 72 hours with discontinuation of neuroleptics, supportive care, and lorazepam. The NMS rating scale reflected daily clinical improvement.

CONCLUSION

Classic NMS characterized by muscular rigidity and prominent fever may occur with atypical neuroleptics. Our cases suggest recovery from NMS associated with atypical neuroleptics may be hastened by lorazepam, as was previously reported for NMS from typical neuroleptics. Also, the NMS rating scale was sensitive to clinical improvement.

摘要

目的

作者报告了三例由非典型抗精神病药物(奥氮平和氯氮平)引起的神经阻滞剂恶性综合征(NMS),这些病例均表现出 NMS 的典型特征,包括肌肉僵硬和明显发热。

方法

病例报告。

结果

一名 66 岁患有痴呆和酒精滥用的男性,因激越和攻击行为而服用奥氮平后发生 NMS。一名 62 岁患有精神分裂症的男性在开始服用氯氮平 6 天后发生 NMS。一名 43 岁患有双相情感障碍的男性在开始服用氯氮平 14 天后发生 NMS。所有三例均表现出 NMS 的典型特征,包括肌肉僵硬和发热。停用神经阻滞剂、支持性护理和劳拉西泮后,发热和肌肉僵硬在 72 小时内得到缓解。NMS 严重程度评分反映了每日的临床改善。

结论

经典的 NMS 以肌肉僵硬和明显发热为特征,可能发生在使用非典型神经阻滞剂时。我们的病例表明,与典型神经阻滞剂引起的 NMS 一样,劳拉西泮可能加速与非典型神经阻滞剂相关的 NMS 的恢复。此外,NMS 严重程度评分对临床改善敏感。

相似文献

1
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam.由非典型神经阻滞剂引起的神经阻滞剂恶性综合征,并对劳拉西泮有反应。
Neuropsychiatr Dis Treat. 2006 Jun;2(2):235-40. doi: 10.2147/nedt.2006.2.2.235.
2
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].[病例报告:抗精神病药恶性综合征及诊断难点]
Encephale. 2016 Jun;42(3):277-80. doi: 10.1016/j.encep.2016.01.001. Epub 2016 Feb 26.
3
[Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].[氯氮平相关的抗精神病药恶性综合征继发紧张症:一例报告]
Turk Psikiyatri Derg. 2013 Summer;24(2):140-4.
4
Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.与近期抗精神病药引起的神经阻滞剂恶性综合征病史相关,使用丙氯拉嗪引起的神经阻滞剂恶性综合征。
Ann Pharmacother. 2011 Nov;45(11):e61. doi: 10.1345/aph.1Q325. Epub 2011 Oct 4.
5
Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.齐拉西酮诱导的神经阻滞剂恶性综合征的非典型表现:病例报告。
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241262690. doi: 10.1177/23247096241262690.
6
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物:简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
7
Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.奥氮平诱发的偏执型精神分裂症患者的抗精神病药恶性综合征
Psychiatry Clin Neurosci. 2009 Feb;63(1):119-21. doi: 10.1111/j.1440-1819.2008.01894.x. Epub 2008 Dec 1.
8
Olanzapine induced neuroleptic malignant syndrome--a case review.奥氮平诱发的抗精神病药恶性综合征——病例回顾
Hum Psychopharmacol. 2003 Jun;18(4):301-9. doi: 10.1002/hup.483.
9
Atypical neuroleptic malignant syndrome associated with olanzapine.与奥氮平相关的非典型抗精神病药恶性综合征。
Pharmacotherapy. 2002 May;22(5):641-4. doi: 10.1592/phco.22.8.641.33211.
10
[Acute catatonic syndrome after neuroleptic malignant syndrome].[抗精神病药恶性综合征后的急性紧张症综合征]
Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. doi: 10.1016/s0013-7006(05)82429-7.

引用本文的文献

1
Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.静脉注射丹曲林治疗代谢亢进综合征:美国退伍军人事务部数据库调查。
BMC Anesthesiol. 2022 Sep 19;22(1):298. doi: 10.1186/s12871-022-01841-z.
2
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.氯氮平所致心血管副作用及自主神经功能障碍:一项系统评价
Front Neurosci. 2018 Apr 4;12:203. doi: 10.3389/fnins.2018.00203. eCollection 2018.
3
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

本文引用的文献

1
Is Lorazepam a treatment for neuroleptic malignant syndrome?劳拉西泮是否可用于治疗神经安定恶性综合征?
CNS Spectr. 2000 Jul;5(7):54-7. doi: 10.1017/s1092852900013407.
2
Diazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype?
Am J Psychiatry. 1997 Jun;154(6):882. doi: 10.1176/ajp.154.6.882.
3
Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.氯氮平所致的抗精神病药恶性综合征:新病例回顾与报告
J Clin Psychopharmacol. 1995 Oct;15(5):365-71. doi: 10.1097/00004714-199510000-00010.
第二代抗精神病药物与神经阻滞剂恶性综合征:系统评价与病例报告分析
Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0.
4
Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?非典型抗精神病药在治疗痴呆的行为和心理症状方面比典型抗精神病药更安全吗?
J Nutr Health Aging. 2012;16(6):557-61. doi: 10.1007/s12603-012-0057-5.
5
Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.甲氧氯普胺过量所致神经阻滞剂恶性综合征与艰难梭菌腹泻并存
Intensive Care Med. 2011 Oct;37(10):1706-8. doi: 10.1007/s00134-011-2250-0. Epub 2011 Jun 18.
6
Catatonia: diagnosis, classification, and treatment.紧张症:诊断、分类与治疗。
Curr Psychiatry Rep. 2010 Jun;12(3):180-5. doi: 10.1007/s11920-010-0113-y.
4
Case study: neuroleptic malignant syndrome without pyrexia.病例研究:无发热的抗精神病药恶性综合征
J Am Acad Child Adolesc Psychiatry. 1996 Jul;35(7):959-62. doi: 10.1097/00004583-199607000-00024.
5
Neuroleptic malignant syndrome and catatonia: one entity or two?抗精神病药恶性综合征与紧张症:是同一实体还是两种疾病?
Biol Psychiatry. 1996 Jan 1;39(1):1-4. doi: 10.1016/0006-3223(95)00552-8.
6
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Med Clin North Am. 1993 Jan;77(1):185-202. doi: 10.1016/s0025-7125(16)30278-4.
7
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Am J Psychiatry. 1985 Oct;142(10):1137-45. doi: 10.1176/ajp.142.10.1137.